Cargando…
Antimullerian hormone is a predictor of live birth in patients with recurrent pregnancy loss
BACKGROUND: Ovarian reserve testing is not routinely performed in the evaluation of recurrent pregnancy loss (RPL). The objective of this study was to determine if AMH levels are predictive of live birth rate in RPL patients pursuing expectant management (EM). METHODS: Retrospective cohort study of...
Autores principales: | Murugappan, Gayathree, Shahine, Lora, Lathi, Ruth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419824/ https://www.ncbi.nlm.nih.gov/pubmed/30923623 http://dx.doi.org/10.1186/s40738-019-0054-z |
Ejemplares similares
-
Time to next pregnancy in spontaneous pregnancies versus treatment cycles in fertile patients with recurrent pregnancy loss
por: Perfetto, Candice O, et al.
Publicado: (2015) -
Maternal antimullerian hormone as a predictor of fetal aneuploidy occurring in an early pregnancy loss
por: Shim, So Hyun, et al.
Publicado: (2015) -
Can high antimüllerian hormone mitigate some of the age-related decline in live birth rates? The association between antimüllerian hormone and live birth among women over 40 undergoing in vitro fertilization
por: Harris, Benjamin S., et al.
Publicado: (2021) -
Prognostic value of blastocyst grade after frozen euploid embryo transfer in patients with recurrent pregnancy loss
por: Murugappan, Gayathree, et al.
Publicado: (2020) -
Impact of increasing antimüllerian hormone level on in vitro fertilization fresh transfer and live birth rate
por: Acharya, Kelly S., et al.
Publicado: (2022)